Regulatory Briefs: CLIA Update; Product Reclassification; Thrombogenicity Workshop
This article was originally published in The Gray Sheet
FDA provides a Clinical Laboratory Improvement Amendments administrative procedures guidance update. Absorbable lung biopsy plugs are reclassified. FDA will host a public workshop to discuss methods for thrombogenicity testing on April 14.
You may also be interested in...
According to an updated guidance on FDA’s eCopy submission program, it now accepts a broader range of PDFs. The update contains expanded guidelines for industry when submitting electronic versions of applications to FDA.
Former managing director of Janssen India to helm Bharat Serums and Vaccines following the firm’s acquisition by private equity firm Advent International.